Sensiotec UWB Monitor Gets FDA Clearance

Atlanta-based Sensiotec has received FDA 510(k)
Class II clearance for its ultra-wideband (UWB) non-contact,
continuous monitor for heart and respiration rates. The device,
Preventa, will be marketed and sold in the U.S. and Canada.

According to the company, Preventa is the world’s first medical
device to harness UWB, a former classified military technology, to
create a wireless vital signs monitor. The device monitors heart,
respiration rates and movement, and also alerts caregivers when a
patient requires relocation to help prevent bed sores. Because
patients can be watched remotely, caregivers gain a disease
management tool that can help reduce complications associated with
common chronic illnesses such as heart disease, COPD and sleep
apnea and reduce hospital admissions and ER visits.

Sensiotec CTO Efraim Gavrilovich states, “Wireless monitoring
has great potential as an early warning system that helps to
identify and manage health crises when they arise.”